Prx (peroxiredoxin) 2 protects cells from deleterious oxidative damage. It catalyses the breakdown of hydroperoxides through a highly reactive cysteine residue and has been linked to chaperone activity that promotes cell survival under conditions of oxidative stress. It may also be involved in redox signalling by binding to other proteins. In the present study we have searched for binding partners of Prx2 in H 2 O 2 -treated Jurkat and human umbilical vein endothelial cells and discovered that the hyperoxidized form selectively co-precipitated with the protein disulfide-isomerase ERp46. Mutant analyses revealed that loss of the peroxidative cysteine residue of Prx2 also facilitated complex formation with ERp46, even without H 2 O 2 treatment, whereas the resolving cysteine residue of Prx2 was indispensible for the interaction to occur. The complex involved a stable non-covalent interaction that was disassociated by the reduction of intramolecular disulfides in ERp46, or by disruption of the decameric structure of hyperoxidized Prx2. This is the first example of a protein interaction dependent on the hyperoxidized status of a Prx.
INTRODUCTION
Prxs (peroxiredoxins) belong to a highly conserved family of thiol proteins that display exceptional reactivity with hydroperoxides, thereby contributing to cellular antioxidant defence [1] [2] [3] . The Prxs also have a role in redox signalling, although the mechanisms are less well defined. Mammals have six highly abundant Prxs, but there is limited redundancy within the family. For example, Prx1 and Prx2 are both present at high concentrations within the cytoplasm, and they have a similar capacity to decompose hydroperoxides, but mice in which the individual Prxs are deleted display severe and distinct pathologies [4] [5] [6] , suggesting specialist roles. Also, Prx1 and Prx2 differentially compensate for loss of their orthologue TSA1 in yeast knockout studies [7] and do not have common interaction partners [3] .
Typical two-cysteine Prxs (Prx1-Prx4) predominantly exist as non-covalent homodimers. They have a highly conserved active site featuring a strongly nucleophilic cysteine residue (C p , peroxidative cysteine) in each dimer subunit. This cysteine residue is essential for antioxidant activity and is readily oxidized to a sulfenic acid by hydroperoxides ( Figure 1a ). The sulfenic acid subsequently reacts with a cysteine residue (C r , resolving cysteine) on the other Prx subunit to form a disulfide-linked homodimer [8, 9] . The disulfide is recycled by thioredoxin, coupled with thioredoxin reductase and the electron donor NADPH [8, 10] , completing the catalytic cycle.
On exposure to excess H 2 O 2 , the C p sulfenic acid can be oxidized to a sulfinic acid before dimerization with the C r , in a process termed hyperoxidation (or overoxidation) [11, 12] . The C p sulfinic acid can be recycled back to the reduced cysteine residue by sulfiredoxin in a relatively slow process that requires ATP [13, 14] . Prokaryotic Prxs are typically more resistant to hyperoxidation than their eukaryotic equivalents, which have acquired a C-teminal extension that facilitates hyperoxidation and inactivation of catalytic function [13, 15, 16] . These extensions were interpreted as a gain-of-function for eukaryotic Prxs, potentially as redox sensors that transmit signals within cells. The 'floodgate' hypothesis [15] proposes that Prxs keep H 2 O 2 levels low in regions within the cell, until they are inactivated by hyperoxidation [17, 18] . Alternatively, the hyperoxidized Prxs could acquire novel functionality. For example, Prxs form toroidal decamers, and in some cases stacks of decamers, that are not dependent on disulfide formation for structural stability [19] , but are sensitive to pH and Prx concentration [20] . Hyperoxidation appears to promote stabilization of these structures [21] [22] [23] [24] (Figure 1b) , which have been linked to increased chaperone activity for Prx1 and Prx2 [3, 15, 25] . Structural modification could therefore influence cell signalling through alterations in binding partners in a redox-sensitive manner as observed for yeast [26] . In the present study we have explored the protein interaction partners of Prx2 in cells exposed to H 2 O 2 and reveal evidence for a direct interaction of hyperoxidized Prx2 with ERp46, a member of the were confirmed by use of introduced restriction sites and sequencing analyses, and constructs were transformed into BL21 codon + Escherichia coli for protein expression and purification.
MBP (maltose-binding protein)-ERp46
pCDNA5-FRT/TO-ERp46-HA-KDEL [29] was donated by Professor Jonathan Whitehead (University of Queensland, Brisbane, Australia). Restriction endonuclease-digested cDNA fragments HindIII/HindIII and HindIII/XbaI were subcloned into Bluescript-KS + vector (Fermentas), then recloned SalI/XhoI into the Sal I site of pMAL-C2 vector. Clones were confirmed by restriction and sequencing analyses, and pMAL-C2-ERp46 cDNA was transformed into BL21 codon + E. coli for protein expression and purification. The resulting clone expresses N-terminal MBPtagged human ERp46 with a 40-amino-acid linker.
Protein expression and purification
His-Prx2, His-Prx2-C51S and His-Prx2-C172S were expressed in BL21 codon + E. coli by inducing exponential-phase cultures with 1 mM IPTG for 2 h at 30
• C, followed by bacterial lysis in 50 mM Tris/HCl, pH 7.4, 100 mM NaCl, 10 % (v/v) glycerol, 0.1 mM PMSF, 0.1 mg/ml lysozyme and 10 mM imidazole. Lysis by sonication was followed by clarification by centrifugation at 20 000 g at 4
• C. Clarified lysates were applied to 0.5 ml of His-Select Cobalt Affinity Gel (Sigma) per litre of culture for 1 h of rotating at 4
• C, followed by several washes with buffer containing 20 mM imidazole, and eluted with 250 mM imidazole before dialysis into 50 mM Tris/HCl, pH 7.4, 100 mM NaCl and 10 % (v/v) glycerol.
MBP-ERp46 was expressed as above, but lysates (without imidazole) were incubated with 1 ml of amylose resin (Biolabs) per litre of culture with overnight rotation at 4
• C. Several washes with lysis buffer were followed by elution with 10 mM maltose in lysis buffer and dialysis into 20 mM Tris/HCl, pH 7.4, 100 mM NaCl and 10 % (v/v) glycerol. Preparations were stored in aliquots at − 80
• C.
Reduction and oxidation of recombinant proteins
All buffers were pre-treated with 10 μg/ml catalase (to remove any residual buffer H 2 O 2 ) and 100 μM DTPA (diethylenetriaminepenta-acetic acid) (to chelate trace metal contaminants) and ultra-filtered to remove catalase before use. Recombinant protein (10-50 μM) was reduced by incubation with 25 mM DTT in 20 mM Hepes, pH 7.5, 100 mM NaCl and 10 % (v/v) glycerol for 30 min at 20
• C. For hyperoxidation, His-Prx2 wt or HisPrx2-C172S was reduced as above and then 5 mM H 2 O 2 was added in the presence of DTT for 30 min at 20
• C. His-Prx2 disulfide was produced by treating 50 μM reduced protein with 500 μM ammonia/chloramine for 30 min at 20
• C. All treated proteins were re-buffered to remove additives by centrifugation through pre-equilibriated Bio-Gel P-6 DG desalting gel (Bio-Rad Laboratories) in spin columns according to the manufacturer's instructions.
In vitro reactions
His-Prx2 (2.5 μM) and ERp46 were incubated in 20 mM Hepes, pH 7.5, 100 mM NaCl and 10 % (v/v) glycerol for 10 min at 20
• C. Reactions were stopped by treatment with 20 mM NEM (N-ethylmaleimide) for 30 min before addition of non-reducing or reducing Laemmli buffer [60 mM Tris/HCl, pH 6.8, 2 % (w/v) SDS, 5 % (v/v) glycerol, 0.01 % (w/v) Bromophenol Blue and 320 mM 2-mercaptoethanol] for SDS/PAGE analysis.
Cell culture, treatment and lysis
The Jurkat (T-lymphocyte) cell line was maintained in RPMI 1640 medium (RPMI) supplemented with 10 % (v/v) FBS and penicillin/streptomycin (Invitrogen) (complete RPMI medium) at (0.2-1.0)×10 6 cells/ml. Cells were harvested by centrifugation and resuspended to 1×10 7 cells/ml in complete RPMI medium and either untreated or supplemented with 200 μM H 2 O 2 for 10 min at 37
• C. In some experiments, cells were pelleted and resuspended in 20-100 mM NEM in PBS for 20 min at 4
• C. HUVECs (human umbilical vein endothelial cells) were obtained with informed consent and ethical approval from the Upper South A Regional Ethics Committee, New Zealand (CTY/02/12/209). They were isolated as previously described [30, 31] (20-30 strokes) followed by centrifugation at 14 000 g for 10 min at 4
• C. Clarified lysate proteins were quantified by the standard Bradford method with Bio-Rad Reagent.
Size-exclusion chromatography of endogenous proteins
Jurkat cells were treated with 200 μM H 2 O 2 for 10 min at 37
• C and/or 100 mM NEM for 20 min at 4
• C, then lysed in lysis buffer. Clarified extracts from 1×10 7 cells were resolved through a Biosep-SEC-S3000 HPLC column (Phenomenex) using lysis buffer without glycerol or Igepal CA630 as the mobile phase with a flow rate of 0.5 ml/min. Fractions were collected at 1-2 min intervals and then concentrated by precipitation with 0.1 % sodium deoxycholate, 20 % (v/v) trichloroacetic acid and 20 % (v/v) acetone for 1 h at − 20
• C. Precipitates were washed three times with cold acetone and then resuspended in reducing Laemmli buffer for SDS/PAGE analyses. Molecular mass standards comprising Blue Dextran (void volume limit), ferritin, catalase, BSA and cytochrome c were run under identical conditions.
Immunoprecipitation of endogenous Prx2 and ERp46
Rabbit IgG (a gift from Barry Hock, Haematology Research Group, University of Otago, Dunedin, New Zealand), rabbit anti-Prx2 (Sigma R8656) or goat anti-ERp46 (Abcam ab13820) antibodies were immobilized on to Dynabeads ® (Dynal/Invitrogen) according to the manufacturer's instructions. Cells from Jurkat or HUVEC lines were treated with 200 μM H 2 O 2 for 10 min at 37
• C and/or 20-100 mM NEM for 20 min at 4
• C, lysed as described above and clarified lysates from 1×10 8 cells were incubated with antibodies conjugated to Dynabeads ® (400 μl) overnight with rotation at 4 • C. The beads were collected with a magnet and subjected to five washes in lysis buffer. Disulfide-linked proteins were then eluted by incubation of the beads in lysis buffer containing 10 mM DTT for 10 min at 4
• C. The beads were separated from eluates, washed twice in lysis buffer and then treated with low-pH buffer (0.1 M glycine, pH 3) to remove all non-covalently bound proteins and the antigen. In some experiments the DTT elution step was omitted to preserve complexes for further analyses. Eluates were concentrated by precipitation and treated as above for SDS/PAGE analyses.
Endogenous Prx2 depletion from lysates and immunoprecipitations with recombinant His-Prx2
Clarified Jurkat cell lysates from 1×10 8 cells were incubated with rabbit anti-Prx2 antibody-conjugated Dynabeads ® (400 μl) for 45 min rotating at 4
• C. Beads were collected with a magnet and recycled with three washes with 0.1 M glycine, pH 3, followed by a wash in lysis buffer. They were then re-incubated with the partially Prx2-depleted lysates for 45 min and the process was repeated for a total of three depletions. The Prx2-depleted lysates were then spiked with 20 μg of purified His-Prx2, HisPrx2-C51S or His-Prx2-C172S recombinant protein and rotated for 10 min at 4
• C. These were then left untreated or treated with 200 μM H 2 O 2 for 10 min at 4 • C, then added to antiPrx2-Dynabeads ® with overnight rotation at 4
• C, or nickelSepharose 6 Fast Flow beads (GE Healthcare) (with prior addition of 5 mM imidazole) with rotation for 1 h at 4
• C. Dynabeads ® were processed as described above. Nickel-Sepharose beads were washed in lysis buffer containing 20-250 mM imidazole as described. Eluates were precipitated as described above.
Cell fractionations
Untreated or H 2 O 2 (200 μM)-treated HUVEC or Jurkat cells were fractionated by successive differential centrifugations in sucrose as follows. The cells (3×10 7 or 1×10 8 respectively) were resuspended in sucrose buffer (20 mM Tris/HCl, pH 7.4, 1 mM EDTA and 250 mM sucrose), allowed to swell, then the plasma membranes were broken (cavitated) by nitrogen decompression using a Parr Cell Disruption Bomb 4635 (Parr Instrument Company) at 375 psi (1 psi = 6.9 kPa) for 5 min. Cavitated cells were centrifuged at 885 g for 5 min at 4
• C to isolate nuclei. The remaining cytoplasmic fractions were centrifuged at 18 000 g for 20 min at 4
• C to isolate membranous organelles. These were washed twice by resuspension in fresh buffer and re-centrifugation. Supernatants (cytosol and plasma membranes) were re-centrifuged twice to pellet any residual organelles. Samples were resuspended in reducing Laemmli buffer for SDS/PAGE and immunoblotting.
SDS/PAGE and immunoblotting
Samples were resolved by reducing or non-reducing SDS/PAGE (10 % gels). For MS protein identification, 8-16 % acrylamide gradient gels were used. Resolved samples were either silver stained or transferred on to PVDF membranes for immunoblotting with rabbit anti-Prx2 (Sigma R8656), goat anti-ERp46 (Abcam ab13820 and Santa Cruz Biotechnology sc-49660), mouse antiPrx4 (Abcam ab16943), rabbit anti-PrxSO 2/3 H (Abfrontier LF-PA0004), mouse anti-calnexin (Sigma C7617) and mouse anti-PDI (Abcam ab2792) antibodies. Secondary antibodies used were horseradish peroxidase-conjugated goat anti-rabbit (for Prx2 and PrxSO 2/3 H) (DAKO P044801), goat anti-mouse (for Prx4, calnexin and PDI) (DAKO P044701) and rabbit anti-goat (for ERp46) (Sigma A5420). Anti-Prx2 and anti-ERp46 antibodies were also used for immunoprecipitations as described above.
Protein band identification by MS
Protein band identification was performed by the Centre for Protein Research (University of Otago, Dunedin, New Zealand) and are described in brief. Excised protein bands were subjected to in-gel digestion with trypsin using a robotic workstation for automated protein digestion as described previously [32] . Eluted peptides were dried using a centrifugal concentrator. Samples were re-solubilized in 1 % (v/v) acetonitrile and 0.2 % formic acid in water and injected on to an Ultimate 3000 nano-flow LCSystem (Dionex) that was in-line coupled to the nano-electrospray source of a LTQ-Orbitrap XL hybrid mass spectrometer (Thermo Scientific). Peptides were separated, ionized and fragmented. For protein identification MS/MS data were searched against the SWISS-PROT amino acid sequence database using the Mascot search engine (http://www.matrixscience.com).
Immunostaining and fluorescence microscopy
HUVECs were cultured on to gelatin (0.1 %)-coated coverslips in 24-well plates in complete RPMI medium. After overnight incubation, the cells were treated with 200 μM H 2 O 2 for 10 min at 37
• C, then were washed twice in PBS, fixed for 20 min at 20
• C in 4 % paraformaldehyde, 2 % sucrose, and washed twice in PBS. Cells were permeablized with 0.25 % Triton X-100 in PBS for 20 min at 20
• C, followed by three washes in PBS. Permeablized cells were blocked for 1 h at 20
• C in 10% BSA (Fraction V, Invitrogen) in PBS, and then incubated overnight at 4
• C with the primary antibodies mouse anti-Prx4 (Abcam ab16943, 1:500 dilution) and goat anti-ERp46 (Santa Cruz Biotechnology sc-49660, 1:100 dilution) diluted in 3 % BSA in PBS. Coverslips that were not incubated with primary antibodies were used as controls. Cells were washed three times with PBS, followed by incubation for 1 h at 20
• C with the secondary antibodies, Alexa Fluor ® 594 donkey anti-mouse IgG (Invitrogen A-21203, 1:1000 dilution) and Alexa Fluor ® 488 rabbit anti-goat IgG (Invitrogen A-21222, 1:1000 dilution) in 3 % BSA in PBS. Cells were washed three times with PBS and then incubated for 20 min at 20
• C, with 10 μg/ml DAPI to stain nuclei, followed by five washes with PBS. Coverslips were mounted on to slides in Fluoromount G (In Vitro Technologies). A Zeiss AxioImager Z1 microscope with a zeiss, AxioCam HRc camera was used to visualize and photograph cells.
RESULTS

Anti-Prx2 antibody immunoprecipitates ERp46 from H 2 O 2 -treated cells
Treatment of Jurkat cells with 200 μM H 2 O 2 caused Prx hyperoxidation as detected using the anti-PrxSO 2/3 antibody specific to the conserved C p sulfinic acid epitope (Figure 2a , left-hand panel). Reduced (monomeric) Prx2 is predominantly oxidized to disulfide-linked dimers by endogenous peroxides upon cell lysis [33] . Prevention of dimer formation upon cell lysis is evidence that the majority of Prx2 from cells treated with H 2 O 2 was already hyperoxidized (Figure 2a To search for proteins that interact with Prx2, anti-Prx2 antibody was irreversibly cross-linked to Protein A-coated Dynabeads ® which were incubated with lysates of Jurkat cells. The beads were sequentially eluted with DTT to isolate disulfidelinked Prx2 interactors, followed by glycine, pH 3, to elute non-covalently bound proteins (Figure 2b ). One major protein from lysates from H 2 O 2 -treated cells (in which the Prx2 was hyperoxidized), but not control cells, was consistently eluted with DTT. This protein was identified by MS of the trypsin-digested silver-stained SDS/PAGE band and subsequently confirmed by immunoblotting as the PDI ERp46. Matched unique peptide sequences covered 37 % of the full-length protein (Supplementary  Table S1 at http://www.biochemj.org/bj/453/bj4530475add.htm). ERp46 contains 12 cysteine residues, including three pairs of thioredoxin-like domains, and contributes to disulfide bond formation in the ER (endoplasmic reticulum) [34] .
Reciprocal pull-downs with anti-ERp46 indicated selective capture of Prx2 from H 2 O 2 -treated cells, and immunoblots with anti-PrxSO 2/3 indicated that the immunoprecipitated Prx2 was hyperoxidized ( Figure 2c ). As ERp46 is highly expressed in endothelial cells [35] , we also performed Prx2 immunoprecipitations on lysates from HUVECs that were either untreated or treated with 200 μM H 2 O 2 . The interaction was again observed, and displayed the same dependence on exposure to H 2 O 2 ( Figure 2d) .
As other researchers have observed redox activity between PDIs and Prx4 [36, 37] , we investigated whether Prx4 could also form a protein-protein interaction with ERp46. We performed separate immunoprecipitations from Jurkat cell lysates with an anti-Prx4 antibody and the ERp46 antibody immobilized on Dynabeads ® . As shown in Supplementary Figure S2 (at http://www.biochemj. org/bj/453/bj4530475add.htm), Prx4 immunoprecipitation copurified ERp46. The reciprocal ERp46 precipitation co-purified Prx4 in a thiol-dependent manner as Prx4 was released from antiERp46 antibody-Dynabeads ® with DTT.
Recombinant His-Prx2 protein recapitulates the interaction with endogenous ERp46
In order to characterize the mechanism of the interaction between Prx2 and ERp46, we prepared recombinant N-terminal Histagged wt Prx2 and mutant proteins, where either C p (Cys 51 ) or C r (Cys 172 ) was replaced with serine. Purity is shown in Supplementary Figure S3 Prx2 was immunodepleted from Jurkat cell lysates to prevent competition with the recombinant protein (Figure 3b ) and the recombinants were added to determine their ability to interact with endogenous ERp46. Addition of hyperoxidized His-Prx2 wt resulted in ERp46 co-precipitating with antiPrx2 antibody and eluting from the antibody-bound beads with DTT (Figure 3c, lane 1) . In contrast, untreated HisPrx2 wt protein had minimal interaction with ERp46 (lane 2). His-Prx2-C51S also immunoprecipitated ERp46 from the lysate, but without exposure to exogenous oxidant (lane 3), suggesting that the loss of C p mimics hyperoxidation. Replacement of the C r with serine (His-Prx2-C172S) removed the ability of Prx2 to co-purify ERp46 (lane 4), even when the C p was hyperoxidized (Figure 3d ). This suggests that the C r is important for facilitating interaction with ERp46. The most obvious explanation for the ability of DTT to reverse the interaction is by reduction of an intermolecular disulfide. However, the results could also be explained if binding depended on an internal disulfide in ERp46. To test these possibilities, Prx2-depleted cell lysates were untreated or reduced with DTT and passed through a desalting column to remove the reductant, then the interactions between ERp46 and recombinant His-Prx2-C51S were monitored. Immunoprecipitation of Prx2 revealed that ERp46 from untreated lysates bound to the Prx as expected, whereas the reduced ERp46 did not (Figure 3e ). These data confirm that a disulfide within ERp46 is necessary to facilitate their interaction.
Isolated Prx2 and ERp46 lack detectable mixed disulfides
As well as requiring an intramolecular disulfide, it is still possible that the interaction between Prx2 and ERp46 involves an intermolecular disulfide. To examine directly whether mixed disulfides were present in the immunoprecipitated material, proteins were eluted from the beads directly with pH 3 buffer and separated on non-reducing gels. The ERp46 was precipitated because of its association with Prx2, if the interaction involves an intermolecular disulfide the majority of the ERp46 should be shifted to a higher-molecular-mass band on a non-reducing gel. Instead, ERp46 predominantly ran in its monomer position ( Figure 4, blot 2) , when comparing elutions with DTT (lane 1) or at pH 3 (lane 3). Some ERp46 did migrate at approximately
Figure 4 Prx2 and ERp46 eluted from immunoprecipitations lack mixed disulfides
Non-reducing SDS/PAGE immunoblots of Prx2-immunoprecipitated eluates from untreated ( − ) or H 2 O 2 -treated ( + ) Jurkat cell extracts. Elutions from Dynabeads ® were performed with DTT followed by pH 3 buffer (pH 3 after DTT), compared with pH 3 buffer alone (pH 3 only). Blots 1 and 3 were immunoblotted without primary antibodies for ERp46 or Prx2, to control for blots 2 and 4 respectively. Non-specific bands are marked (*). Molecular masses in kDa are indicated. 2 • , secondary.
70 kDa in pH 3 elutions, but the anti-Prx2 antibody immunoblot shows that Prx2 eluted at pH 3 was not present in that small proportion of 70 kDa ERp46 mixed disulfides (compare blots 2 and 4, lanes 3). Note that blots 1 and 3, where only secondary antibodies (horseradish peroxidase-conjugated anti-goat or antirabbit respectively) were used, represent controls for blots 2 and 4 respectively. These reveal bands above 100 kDa on the ERp46 blot, and above 37 kDa on the Prx2 immunoblot that are nonspecific (*) and may be IgG-related. In conclusion, although the association between the two proteins was disrupted by disulfide reduction, there was no evidence that it involved a stable covalent bond between them.
Effects of NEM on endogenous ERp46-Prx2 interactions
The interaction of Prx2 and ERp46 was observed without adding a thiol-blocking reagent prior to cell lysis. As this is commonly done to prevent subsequent thiol oxidation or exchange, we performed a similar experiment with NEM added to the cells after H 2 O 2 treatment. NEM (100 mM) (or 20 mM, results not shown) added before lysis, or to the lysate (results not shown), resulted in loss of the Prx2-ERp46 interaction (Figure 5a , compare lanes 5 and 6). To determine whether alkylation disrupted complexes that had already formed, NEM was added to the washed beads following immunoprecipitation of Prx2 from H 2 O 2 -treated lysates (Figure 5b ). NEM caused ERp46 to elute from the Prx2-ERp46 complex bound to the beads (lane 8) such that none remained to elute with DTT (lane 2). In comparison, 1 M NaCl, which should disrupt ionic interactions (lane 9), had no effect on complex integrity, with the ERp46 remaining bound to the Prx2 until it was eluted with DTT (lane 3). In each case, Prx2 remained bound to the beads until the pH 3 elution. NEM also disrupted the ERp46-Prx2 complex when His-Prx2 was captured with nickelSepharose beads rather than the anti-Prx2 antibody. ERp46 was also captured with hyperoxidized Prx2 in this system (Figure 5c , lane 2), but after incubation with 20 mM NEM for 10 min little remained to elute from the beads with Prx2 (Figure 5c, lane 3) . As NEM cannot disrupt pre-existing disulfides this is further support for the interaction between the two proteins being non-covalent. It also suggests that NEM causes a conformational change to one or both proteins that disrupts the interaction. We examined the effects of H 2 O 2 and NEM on the oligomeric state of the proteins by subjecting Jurkat cell lysates to sizeexclusion chromatography. As shown in Figure 6 (top panel), Prx2 from control lysate, which would have been present as disulfides due to oxidation of the reduced form during cell lysis (Figure 2a , right-hand panel), was spread over a >200 kDa molecular mass range. Prx2 forms non-covalent decameric toroid structures which can dissociate into dimers (especially in the disulfide state) or form small stacks of decamers to give higher-molecular-mass structures [19] . Under these conditions, Prx2 would be present as disulfides in decameric or larger structures. The observed size distribution was dramatically affected by NEM, which eliminated the decamers and caused the Prx2 to run in lower-molecularmass fractions. Prx2 that was hyperoxidized by treating the cells with H 2 O 2 ran in the decamer or higher-molecular-mass positions. This is consistent with the hyperoxidized form (as shown by blotting with anti-PrxSO 2/3 , Figure 6 , middle four panels) forming a very stable decamer. Alkylation with NEM, however, prevented decamer formation and the hyperoxidized protein ran in the dimer region. The mobility of ERp46 ( Figure 6 , lowest four panels) was much less affected by NEM. In extracts from control or H 2 O 2 -treated cells, it ran predominantly in a range of higher-molecularmass positions than the expected monomer. NEM had no marked effect on the mobility of ERp46.
To rule out the possibility that the detergent (Igepal CA630/Nonidet P40) in the lysis buffer facilitated disruption of decamers by NEM, size-exclusion chromatography was also performed on extracts obtained without detergent. Prx2 blots showed exactly the same patterns as in Figure 6 (results not shown), indicating that the effects of NEM are clearly independent of detergent. These results indicate that derivatization with NEM dramatically affects the oligomeric structure of Prx2 and this could prevent interaction with ERp46.
Subcellular localization of ERp46
For Prx2 to interact with ERp46 physiologically, the proteins would need to be present in the same cellular compartment. ERp46 is primarily localized to the ER, but has also reportedly been found in cytosolic and membrane fractions [29, 38] . Prx2 is predominantly cytosolic, but also localizes to plasma membranes [18, 29] . To determine the locality of these proteins in Jurkat cells, we performed fractionation studies to separate organelles (including ER) from the cytoplasm and plasma membranes. Fractionation methods using homogenization, detergents or freeze-thaw cycles have been shown to allow leakage of some PDI activity from ER to cytosol [39] , although PDI (similar to ERp46) has been detected in plasma membrane fractions [40] . We used a nitrogen cavitation method in order to minimize this outcome [41, 42] . Our results show that there were no obvious changes in distribution following treatment with H 2 O 2 under conditions that promote hyperoxidation and complex formation with Prx2. Statistics were performed with the SigmaPlot Version 11 software using one-way repeated measures ANOVA followed by the Holm-Sidak multiple comparison method. There was no significant difference when Prx4 was compared with calnexin (*) or when ERp46 was compared with PDI ( + ). Significantly more ERp46 and PDI was present in the ER-depleted cytoplasmic fraction than calnexin or Prx4 (P < 0.05). (c) Immunocytochemistry on HUVECs that were treated with 200 μM H 2 O 2 , then fixed and permeablized. Cells were incubated without (controls, panels 1 and 2) or with (panels 3 and 4) antibodies against Prx4 (mouse IgG) and ERp46 (goat IgG). Fluorescent secondary antibodies were added to detect Prx4 in ER (donkey anti-mouse antibody conjugated to Alexa Fluor ® 594) and ERp46 (rabbit anti-goat antibody conjugated to Alexa Fluor ® 488), together with DAPI to stain nuclei. Fluorescent probes were excited and detected at the appropriate wavelengths and exposure times according to the manufacturer's instructions to reveal Prx4 (red, 50 ms), ERp46 (green, 1 s) and nuclei (cyan, 20 ms). Cells were visualized using differential interference contrast (DIC, 5 ms).
Although small amounts of the ER markers calnexin and Prx4 were present in organelle-depleted cytoplasmic fractions, there was significantly more ERp46 in the cytosolic/plasma membrane fraction than can be explained by ER leakage (Figures 7a and 7b) . PDI immunoblots reveal the same pattern for PDI as for ERp46. The amounts of ERp46 and PDI in the membrane organelleexcluded fractions were even more prominent for HUVECs, with 45 % of ERp46 and 46 % of PDI detected in these fractions, compared with 7 % and 5 % of Prx4 and calnexin respectively (densitometry of Figure 7a , n = 2). These results suggest that a proportion of ERp46 is present in the ER-depleted cytosolic/plasma membrane fractions that also contain Prx2.
In order to substantiate this conclusion, we incubated H 2 O 2 -treated HUVECs with antibodies against ERp46 and Prx4 (as an ER localization marker) and performed immunocytochemistry using fluorescent marker-conjugated secondary antibodies. Controls were incubated with secondary antibodies only. As shown in Figure 7 (c), ERp46 showed a much more diffuse staining pattern than the ER marker Prx4. The overlay shows that the more intense ERp46 staining localized with the ER marker Prx4, but there was definite staining throughout the remainder of the cell (excluding the nucleus).
Redox interactions of Prx2 and ERp46
Although we found no evidence of mixed disulfides of Prx2 and ERp46, it is still possible that the interaction was initially facilitated by formation of a mixed disulfide. The absence of a complex between the Prx2 C r mutant and ERp46 may be due its inability to form this bond. To assess the possibility of disulfide exchange reactions between ERp46 and Prx2, we tested the ability of recombinant ERp46 to reduce equimolar quantities of oxidized His-Prx2 (Figure 8a ). Reduced MBP-tagged ERp46 (lane 2), but not oxidized MBP-ERp46 (lane 3) was indeed able to reduce oxidized His-Prx2 dimers. Increasing the ratio of reduced MBPERp46 to oxidized His-Prx2 increased the reduction of His-Prx2 ( Figure 8b ), confirming that disulfide exchange can readily occur between Prx2 and ERp46.
DISCUSSION
We have shown that a specific interaction occurs between Prx2 and ERp46 following the exposure of either Jurkat cells or endothelial cells to sufficient H 2 O 2 to cause Prx hyperoxidation. Cysteine to serine residue mutations in the C p and C r of Prx2 promoted or prevented interaction with ERp46 respectively, revealing that the C p of Prx2 is dispensible for the interaction, whereas the C r is important. Prx hyperoxidation is known to stabilize the 'doughnut-shaped' Prx decamers. The addition of NEM disrupted the decamers and reversed the interaction with ERp46, indicating that the oligomeric structure of Prx2 is critical in this interaction. This effect is most likely to be caused by NEM alkylating the resolving or non-catalytic cysteines of Prx2, as we observed only a very slight dissociation (fraction shift) of ERp46 higher-molecular-mass structures following NEM treatment.
DTT also disrupted the interaction, resulting in elution of ERp46 from captured Prx2 complexes. Our initial explanation was that an intermolecular disulfide between the two proteins was involved. However, we were unable to detect mixed disulfides between ERp46 and Prx2, indicating that the captured complexes involved non-covalent interactions. This was confirmed by addition of NEM, which clearly disrupted Prx2 structure and interaction with ERp46, despite being unable to reduce intermolecular disulfides. Furthermore, when DTT was added to lysates before the introduction of Prx2, no complex was able to form. Therefore the ability of DTT to elute ERp46 from Prx2 complexes is best explained through disruption of intramolecular disulfides within ERp46. A proportion of ERp46 also interacts with Prx4 as shown by our reciprocal immunoprecipitations. These interactions are also disrupted by DTT, suggesting a similar mechanism of interaction might occur with Prx4. In vitro redox reactions of Prx4 with various PDIs (including ERp46) have already been demonstrated [36] . Our finding that Prx4 and ERp46 can co-precipitate in a similar fashion to Prx2 and ERp46 therefore suggests a possible mechanism that can facilitate redox interactions between Prx4 and PDIs.
The data indicate that ERp46 requires at least some of its cysteine residues to be oxidized before interaction occurs. ERp46 has 12 cysteine residues, with three pairs of thioredoxin-like domains characteristic of PDIs that catalyse the formation of disulfide bonds during protein synthesis. The remaining cysteine residues of ERp46 are not known to be involved in catalytic activity, but they may have structural roles [34] . We cannot say whether one or more of these domains undergo the critical oxidation step, but one possibility is the C-terminal thioredoxin domain (Cys 381 and Cys 388 ), which is crucial for the structural integrity of ERp46 and is proposed to form an interaction interface for substrate binding [34] . A similar non-covalent interaction between the protein disulfide-isomerase P5 and BiP (immunoglobulin heavychain-binding protein), which is also dependent on intramolecular disulfides, has been described previously [43] .
On the basis of our findings, we propose a mechanism for Prx2-ERp46 interaction as in Figure 9 , whereby intramolecular disulfides within ERp46 change its conformation (i) so that it interacts selectively with hyperoxidized Prx2 decamers (ii). The interaction is controlled by redox-regulated oligomerization of Prx2, and is reversed by reduction of ERp46 disulfides (iii) or loss of decameric Prx2 (iv).
Serine mutants of the peroxidatic cysteine residue of Prx2 have been shown to form stable high-molecular-mass structures that mimic those of hyperoxidized Prxs [19] , and this may account for ERp46 binding to the C p mutant of Prx2. Our observation that NEM disrupted Prx2 oligomeric structures explains why binding of the hyperoxidized form to ERp46 was lost. It could also be relevant to other thiol modifications, such as glutathionylation or nitrosylation, which may regulate Prx oligomerization in a similar manner [44, 45] . It was unexpected that mutation of the C r prevented interaction with ERp46, even though no mixed disulfide was involved. C r mutants of Prxs retain their oligomeric structures [46] , so breakdown of the hyperoxidized oligomer is unlikely to be the explanation. One possibility is that mutation alters the Cterminus of Prx2 in such a way to affect binding. Alternatively, there may be an initial thiol-dependent interaction between ERp46 and Prx2 involving the C r that leads to formation of the stable noncovalent complex. Further study is required to reveal the exact nature of the interaction.
ERp46 is primarily localized in the ER, but a fraction has been reported to be present in the cytoplasm and at the plasma membrane [29, 38] . Our cell fractionation results and immunocytochemistry are both consistent with these findings. Compared with two other ER-localized proteins, calnexin and Prx4, there was significantly more ERp46 and PDI in the non-ER fractions from Jurkat cells. The amounts of ERp46 and PDI in the non-ER fraction were even more pronounced with HUVECs, and this was reflected in the fluorescent antibody labelling of Prx4 and ERp46 in fixed and permeablized HUVECs, where ERp46, but not Prx4, was detected throughout the cells. On this basis, it is unlikely that all of the ERp46 and PDI in the cytosolic fraction arose from ER rupture during nitrogen cavitation, and we conclude that a proportion of ERp46 resides outside the ER in both HUVECs and Jurkat cells. Although our immunoprecipitations were performed on whole-cell lysates and would include ERp46 extracted from the ER as well as other compartments, Prx2 is therefore likely to encounter ERp46 outside the ER, and formation of a complex is physiologically possible. The amount of ERp46 that appears to be present outside of the ER is small compared with the large quantities of Prx2. Furthermore, ERp46 is only able to bind to hyperoxidized Prx2. This means that the observed interaction is unlikely to compromise Prx antioxidant capacity. However, it has the potential to influence ERp46 function or act as an oxidant-sensitive signal. ERp46 has been detected in lipid rafts where it is proposed to inhibit NOX2 activation in response to statin treatment [38] , and has also been shown to influence adiponectin receptor activity at the plasma membrane [29] , tolerance to cellular hypoxia [35] and glucose levels in diabetes [47] . Prx2 can also associate with membrane fractions, including lipid rafts and caveoli [18, 48] , so a physiological interaction in plasma membranes is theoretically possible.
Prxs have been shown to form complexes with other binding partners, but apart from the interaction with sulfiredoxin [49] , the present paper is the first report of selective binding to the hyperoxidized form. The first observed interaction was in Saccharomyces cerevisiae, where Orp1 (a Prx) acts as a H 2 O 2 sensor and transmits the redox signal via a mixed disulfide to activate the transcription factor Yap1 [50] . A similar mechanism involving Tpx1 in fission yeast activates the Pap1 transcription factor via an initial sulfenic acid [51, 52] . Mammalian Prx1 has been shown to interact with c-Abl, JNK (c-Jun N-terminal kinase) and ASK1 (apoptosis signal-regulating kinase 1) [53] . In the case of c-Abl and JNK, Prx1 negatively regulates the kinase activities, but oxidative stress dissociates Prx1 with consequent activation of the kinases [54, 55] . In contrast, oxidative stress promotes the formation of a mixed disulfide between Prx1 and ASK1 and facilitates transfer of oxidizing equivalents to form the active disulfide-linked ASK1 multimer [56] . Few binding partners for Prx2 have yet been identified. However, oxidation (or hyperoxidation) of Prx2 regulates a number of signalling pathways [57] . In most cases, for example platelet-derived growth factor receptor signalling [18] , down-regulation or inactivation of Prx2 has been shown to activate the pathway, with activation attributed to H 2 O 2 escaping scavenging by Prx2. Our results suggest that hyperoxidized Prx2 may also be able to influence cellular pathways via interacting partners.
In addition to identifying a redox-regulated interaction between Prx2 and ERp46 that depends on their conformation, we have shown that the proteins undergo a disulfide exchange reaction in which reduced ERp46 reduces the dimeric form of Prx2. In this respect ERp46 acts as a substitute for thioredoxin. This finding is again reminiscent of the reduction of Prx4 by ERp46 and other PDIs [36] , which enables utilization of the oxidizing equivalents of H 2 O 2 for disulfide formation in the ER. Although the role of thioredoxin in recycling Prx2 is well established, it is evident from our result with ERp46, and others with cyclophilins [58, 59] , that Prx2 can interact directly with other proteins with thioredoxin domains. This spread of substrates may enhance the antioxidant capacity of the cell, but, perhaps more significantly, it increases the scope of pathways that could be affected by H 2 O 2 through its reaction with Prx2.
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Figure S2 Reciprocal immunoprecipitations confirm an interaction between Prx4 and ERp46
Left-hand panels: Jurkat cell lysates (1 mg total protein) were immunoprecipitated (ip) overnight with mouse anti-Prx4 antibody (Abcam ab16943) or mouse IgG control antibody (anti-His 6 , Abcam ab18184) (1 μg), then captured with 0.3 mg Protein G-Dynabeads ® (Invitrogen) for 1 h. Dynabeads ® were washed five times with lysis buffer and eluted in Laemmli buffer for SDS/PAGE analyses. Right-hand panels: Jurkat cell lysates (10 mg) were immunoprecipitated with goat anti-ERp46-Dynabeads ® , washed and eluted as described in the Experimental section of the main text. Anti-Prx4 immunoprecipitates or anti-ERp46 concentrated eluates were immunoblotted as shown. Non-specific bands are marked with an asterisk. 
